Clinical Trial Update: A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase II open-label trial evaluating GW786034 in ovarian cancer and peritoneal cancer; study completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Neoplasms Ovarian
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• GW786034

Snippet

Sponsor: GlaxoSmithKline | Conditions: Peritoneal Cancer, Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-01-04